Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.

Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application

Leucht, Stefan, Priller, Josef, Davis, John M. · 2024 · American Journal of Psychiatry

Abstract

The introduction of the first antipsychotic drug, chlorpromazine, was a milestone for psychiatry. The authors review the history, classification, indications, mechanism, efficacy, side effects, dosing, drug initiation, switching, and other practical issues and questions related to antipsychotics. Classifications such as first-generation/typical versus second-generation/atypical antipsychotics are neither valid nor useful; these agents should be described according to the Neuroscience-based Nomenclature (NbN). Antipsychotic drugs are not specific for treating schizophrenia. They reduce psychosis regardless of the underlying diagnosis, and they go beyond nonspecific sedation. All currently available antipsychotic drugs are dopamine blockers or dopamine partial agonists. In schizophrenia, effect sizes for relapse prevention are larger than for acute treatment. A major unresolved problem is the implausible increase in placebo response in antipsychotic drug trials over the decades. Differences in side effects, which can be objectively measured, such as weight gain, are less equivocal than differences in rating-scale-measured (subjective) efficacy. The criteria for choosing among antipsychotics are mainly pragmatic and include factors such as available formulations, metabolism, half-life, efficacy, and side effects in previous illness episodes. Plasma levels help to detect nonadherence, and once-daily dosing at night (which is possible with many antipsychotics) and long-acting injectable formulations are useful when adherence is a problem. Dose-response curves for both acute treatment and relapse prevention follow a hyperbolic pattern, with maximally efficacious average dosages for schizophrenia of around 5 mg/day risperidone equivalents. Computer apps facilitating the choice between drugs are available. Future drug development should include pharmacogenetics and focus on drugs for specific aspects of psychosis.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.20240738

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 133 references

Research works printed but not linked: 14

  1. Laborit H, 1952, Presse Med (1893), 60, 206
  2. Davis JM, 1985, J Clin Psychiatry, 46, 18
  3. Haase HJ, 1954, Der Nervenarzt, 25, 486
  4. Haase HJ, 1983, Der Neuroleptika Dosierung Ein Leitfaden für Klinik und Praxis unter besonderer Berücksichtigung psychotisch Kranker
  5. Abraham D, 1996, Psychiatr Prax, 23, 109
  6. Komossa K, 2010, Cochrane Database Syst Rev, 12, CD008121
  7. Meltzer HY, 1989, Psychopharmacol Bull, 25, 390
  8. Schoemaker H, 1997, J Pharmacol Exp Ther, 280, 83
  9. Wu H, 2024, Cochrane Database Syst Rev, 2, CD015665
  10. Smith RC, 1975, Psychopharmacol Commun, 1, 285
  11. Sampson S, 2013, Cochrane Database Syst Rev, 7, CD006196
  12. World Health Organization, 2023, WHO Model List of Essential Medicines: 23rd List, 2023
  13. Feber L, JAMA Psychiatry
  14. Foucault M, 1961, Folie et déraison: Histoire de la folie à l’âge classique

Cited by

See all 117

Metadata

Authors
Leucht, S., Priller, J., & Davis, J. M.
Affiliations
TUM Klinikum (DE)
Venue
American Journal of Psychiatry
Published
2024-10-01
Volume
181
Issue
10
Pages
865-878
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W4403006239
Cited by
117
References
133
Citations by year
2026: 65 · 2025: 50 · 2024: 2
FWCI
9.32
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
  • DZNE Pub (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
antipsychotic drugs, chlorpromazine, typical antipsychotics, atypical antipsychotics, dopamine antagonists, partial dopamine agonist, schizophrenia, psychosis, relapse prevention, placebo response, antipsychotic adverse effects, weight gain, medication adherence, long-acting injectable antipsychotics, once-daily dosing, dose-response relationship, pharmacogenetics, antipsychotic selection
MeSH terms
Humans, Schizophrenia, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application. https://app.cochat.ai/papers/10.1176/appi.ajp.20240738
The paper
Leucht, S., Priller, J., & Davis, J. M. (2024). Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20240738

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.